Bio-Imaging Technologies Inc. said Thursday that its publicoffering of 1 million units priced at $5 per unit was declaredeffective by the Securities and Exchange Commission. Each unitconsists of one share of common stock and one class Gredeemable common stock purchase warrant.
GKN Securities Corp. managed the offering.
Bio-Imaging (NASDAQ:BITI) of West Trenton, N.J., specializes inconsulting services utilizing quantitative computer imagingtechnology to assist customers in seeking regulatory approvalof drugs and medical devices.
(c) 1997 American Health Consultants. All rights reserved.